Pete Stavropoulos
Analyst
Cantor
Equibles does not estimate personal net worth.
About Pete Stavropoulos
Pete Stavropoulos is recorded as Analyst at Cantor. Pete Stavropoulos has spoken on 2 earnings calls across 2 companies, most recently for Definium Therapeutics, Inc. on November 9, 2026. Those appearances were for Definium Therapeutics, Inc. (DFTX) and Stoke Therapeutics, Inc. (STOK). The companies whose calls Pete Stavropoulos spoke on are classified in the Healthcare sector.
Pete Stavropoulos on recent calls
“With regards to the study designed for PTSD, you know, mainly patient selection, you know, PTSD is a heterogeneous, you know, in terms of trauma exposure, chronicity, you know, psychiatric comorbidities.”
“Ian and team, thanks for taking our questions. The first question that I have is, you know, going back to the Vinland III for the Phase III readout, you know, what gives you confidence that one-year time point is sufficient to sort of see separation between the active arm and sham for the secondaries?”
Affiliation history
-
Cantor
Analyst
Transcript header (unverified)
Current